Meeks Melissa K, Ripley Marcia L, Jin Zhicheng, Rembold Christopher M
Cardiovascular Division, Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA 22908-1395, USA.
Am J Physiol Cell Physiol. 2005 Mar;288(3):C633-9. doi: 10.1152/ajpcell.00269.2004. Epub 2004 Oct 27.
Increases in cyclic nucleotide levels induce smooth muscle relaxation by deactivation [reductions in myosin regulatory light chain (MRLC) phosphorylation (e.g., by reduced [Ca(2+)])] or force suppression (reduction in force without reduction in MRLC phosphorylation). Ser(16)-heat shock protein 20 (HSP20) phosphorylation is the proposed mediator of force suppression. We evaluated three potential hypotheses whereby Ser(16)-HSP20 phosphorylation could regulate smooth muscle force: 1) a threshold level of HSP20 phosphorylation could inactivate a thin filament as a whole, 2) phosphorylation of a single HSP20 could fully inactivate a small region of a thin filament, or 3) HSP20 phosphorylation could weakly inhibit myosin binding at either the thin- or thick-filament level. We tested these hypotheses by analyzing the dependence of force on Ser(16)-HSP20 phosphorylation in swine carotid media. First, we determined that swine HSP20 has a second phosphorylation site at Ser(157). Ser(157)-HSP20 phosphorylation values were high and did not change during contractile activation or forskolin-induced relaxation. Forskolin significantly increased Ser(16)-HSP20 phosphorylation. The relationship between Ser(16)-HSP20 phosphorylation and force remained linear and was shifted downward in partially activated muscles relaxed with forskolin. Neither forskolin nor nitroglycerin induced actin depolymerization as detected using the F/G-actin ratio method in smooth muscle homogenates. These results suggest that force suppression does not occur in accordance with the first hypothesis (inactivation of a thin filament as a whole). Our data are more consistent with the second and third hypotheses that force suppression is mediated by full or partial inhibition of local myosin binding at the thin- or thick-filament level.
环核苷酸水平的升高通过失活(例如,通过降低[Ca(2+)]来降低肌球蛋白调节轻链(MRLC)磷酸化)或力抑制(在不降低MRLC磷酸化的情况下降低力)诱导平滑肌松弛。Ser(16)-热休克蛋白20(HSP20)磷酸化是力抑制的潜在介导因子。我们评估了Ser(16)-HSP20磷酸化调节平滑肌力的三个潜在假设:1)HSP20磷酸化的阈值水平可使整个细肌丝失活;2)单个HSP20的磷酸化可使细肌丝的一个小区域完全失活;3)HSP20磷酸化可在细肌丝或粗肌丝水平上微弱抑制肌球蛋白结合。我们通过分析猪颈动脉中膜力对Ser(16)-HSP20磷酸化的依赖性来检验这些假设。首先,我们确定猪HSP20在Ser(157)处有第二个磷酸化位点。Ser(157)-HSP20磷酸化值较高,在收缩激活或福斯可林诱导的松弛过程中没有变化。福斯可林显著增加Ser(16)-HSP20磷酸化。在福斯可林松弛的部分激活肌肉中,Ser(16)-HSP20磷酸化与力之间的关系保持线性且向下移动。使用F/G-肌动蛋白比率法在平滑肌匀浆中检测,福斯可林和硝酸甘油均未诱导肌动蛋白解聚。这些结果表明,力抑制并非按照第一个假设(整个细肌丝失活)发生。我们的数据更符合第二个和第三个假设,即力抑制是由细肌丝或粗肌丝水平上局部肌球蛋白结合的完全或部分抑制介导的。